Nephron Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NEPHRON, and what generic and branded alternatives to NEPHRON drugs are available?
NEPHRON has twelve approved drugs.
Drugs and US Patents for Nephron
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nephron | METAPROTERENOL SULFATE | metaproterenol sulfate | SOLUTION;INHALATION | 071855-001 | Jul 14, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Nephron | BUDESONIDE | budesonide | SUSPENSION;INHALATION | 078202-001 | Mar 30, 2009 | AN | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Nephron | BETA-2 | isoetharine hydrochloride | SOLUTION;INHALATION | 086711-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.